BIO-TECHNE Corp (TECH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 500M 1B 1.5B FY09: 264M FY10: 269M FY11: 290M FY12: 314.6M FY13: 310.6M FY14: 357.8M FY15: 452.2M FY16: 499M FY17: 563M FY18: 643M FY19: 714M FY20: 738.7M FY21: 931M FY22: 1.1B FY23: 1.1B FY24: 1.2B FY25: 1.2B FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

0 300M 600M 900M FY09: 208M FY10: 214.1M FY11: 224.9M FY12: 235.8M FY13: 231.1M FY14: 251.4M FY15: 307.3M FY16: 336.7M FY17: 374.5M FY18: 432.1M FY19: 473.5M FY20: 483.2M FY21: 632.9M FY22: 756.5M FY23: 769.8M FY24: 769.7M FY25: 790.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Income Annual

0 150M 300M 450M FY09: 150.8M FY10: 156.3M FY11: 163.1M FY12: 166.2M FY13: 158.5K FY14: 159.8M FY15: 147M FY16: 150.6M FY17: 120.6M FY18: 136.2M FY19: 146.7M FY20: 157.4M FY21: 237.3M FY22: 296.6M FY23: 298.9M FY24: 206.7M FY25: 102.3M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

0 100M 200M 300M FY09: 105.2M FY10: 109.8M FY11: 112.3M FY12: 112.3M FY13: 112.6M FY14: 110.9M FY15: 107.7M FY16: 104.5M FY17: 76.1M FY18: 126.2M FY19: 96.1M FY20: 229.3M FY21: 140.4M FY22: 272.1M FY23: 285.3M FY24: 168.1M FY25: 73.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 150M 300M 450M FY09: 55.9M FY10: 54.9M FY11: 65M FY12: 78.8M FY13: 79.5M FY14: 106.4M FY15: 145M FY16: 162.4M FY17: 188.5M FY18: 210.8M FY19: 240.5M FY20: 255.5M FY21: 298.2M FY22: 349.1M FY23: 366.9M FY24: 389.3M FY25: 429.4M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

0 150M 300M 450M FY09: 111.3M FY10: 111.3M FY11: 127.2M FY12: 126.7M FY13: 123.6M FY14: 136.8M FY15: 139.4M FY16: 144.2M FY17: 143.7M FY18: 170.4M FY19: 181.6M FY20: 205.2M FY21: 352.2M FY22: 325.3M FY23: 254.4M FY24: 299M FY25: 287.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

0 150M 300M 450M FY09: 104.8M FY10: 106.6M FY11: 123.6M FY12: 120.7M FY13: 101.1M FY14: 122.9M FY15: 119.5M FY16: 127.3M FY17: 128.5M FY18: 149.4M FY19: 156.2M FY20: 153.5M FY21: 307.9M FY22: 280.4M FY23: 216.1M FY24: 236.1M FY25: 256.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 60M 120M 180M FY09: 37.9M FY10: 37.3M FY11: 37.2M FY12: 37M FY13: 36.9M FY14: 37M FY15: 37.2M FY16: 37.3M FY17: 37.5M FY18: 38.1M FY19: 38.9M FY20: 39.4M FY21: 161.9M FY22: 164.1M FY23: 161.9M FY24: 160.8M FY25: 159.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 2.50 5.00 7.50 Q4 '10: 2.94 Q1 '11: 2.93 Q2 '11: 2.98 Q3 '11: 2.95 Q4 '11: 3.02 Q1 '12: 3.05 Q2 '12: 3.04 Q3 '12: 3.06 Q4 '12: 3.04 Q1 '13: 3.00 Q2 '13: 2.99 Q3 '13: 3.03 Q4 '13: 3.06 Q1 '14: 3.10 Q2 '14: 3.09 Q3 '14: 3.04 Q4 '14: 3.00 Q1 '15: 2.90 Q2 '15: 3.11 Q3 '15: 2.91 Q4 '15: 2.88 Q1 '16: 2.85 Q2 '16: 2.65 Q3 '16: 2.81 Q4 '16: 2.80 Q1 '17: 2.69 Q2 '17: 2.20 Q3 '17: 1.98 Q4 '17: 2.03 Q1 '18: 1.95 Q2 '18: 3.04 Q3 '18: 2.97 Q4 '18: 3.30 Q1 '19: 3.33 Q2 '19: 2.49 Q3 '19: 3.12 Q4 '19: 2.47 Q1 '20: 2.39 Q2 '20: 4.96 Q3 '20: 4.73 Q4 '20: 5.79 Q1 '21: 6.25 Q2 '21: 4.38 Q3 '21: 4.58 Q4 '22: 2.93 Q1 '23: 1.79 Q2 '23: 1.61 Q3 '23: 1.67 Q4 '23: 1.75 Q1 '24: 1.51 Q2 '24: 1.37 Q3 '24: 1.25 Q4 '24: 1.05 Q1 '25: 0.95 Q2 '25: 1.00 Q3 '25: 0.83 Q2 '12 Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '23 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.